Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Covert

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Ophthalmology|June 29, 2010
Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field lossAmy L Hennessy, Joanne Katz, David Covert, et al.
Current Medical Research and Opinion|August 25, 2004
Association between mean intraocular pressure, disease stability and cost of treating glaucoma in CanadaColin Vicente, John Walker, Yvonne Buys, et al.
The American Journal of Geriatric Pharmacotherapy|May 19, 2009
Self-reported prevalence and factors associated with nonadherence with glaucoma medications in veteran outpatientsBetsy Sleath, Rex Ballinger, David Covert, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|January 17, 2007
Screening for glaucoma in Canada: a systematic review of the literatureThomas R Einarson, Colin Vicente, Márcio Machado, et al.
Ophthalmology|February 7, 2006
Patient-reported behavior and problems in using glaucoma medicationsBetsy Sleath, Alan L Robin, David Covert, et al.
Journal of Glaucoma|December 4, 2003
Cost of glaucoma in Canada: analyses based on visual field and physician's assessmentMichael Iskedjian, John Walker, Colin Vicente, et al.
ISRN Ophthalmology|February 22, 2014
Patient race, reported problems in using glaucoma medications, and adherenceBetsy Sleath, Susan J Blalock, David Covert, et al.
Current Medical Research and Opinion|May 19, 2005
Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysisJohn H Walker, Yvonne Buys, Graham Trope, et al.
Advances in Therapy|June 14, 2017
Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort AnalysisAnanth Viswanathan, Claudio Spera, Anmol Mullins, et al.
Indian Journal of Ophthalmology|December 17, 2008
Patient-reported barriers to glaucoma medication access, use, and adherence in southern IndiaBetsy L Sleath, R Krishnadas, Minhee Cho, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Ophthalmology|June 29, 2010
Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field lossAmy L Hennessy, Joanne Katz, David Covert, et al.
Current Medical Research and Opinion|August 25, 2004
Association between mean intraocular pressure, disease stability and cost of treating glaucoma in CanadaColin Vicente, John Walker, Yvonne Buys, et al.
The American Journal of Geriatric Pharmacotherapy|May 19, 2009
Self-reported prevalence and factors associated with nonadherence with glaucoma medications in veteran outpatientsBetsy Sleath, Rex Ballinger, David Covert, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|January 17, 2007
Screening for glaucoma in Canada: a systematic review of the literatureThomas R Einarson, Colin Vicente, Márcio Machado, et al.
Ophthalmology|February 7, 2006
Patient-reported behavior and problems in using glaucoma medicationsBetsy Sleath, Alan L Robin, David Covert, et al.
Journal of Glaucoma|December 4, 2003
Cost of glaucoma in Canada: analyses based on visual field and physician's assessmentMichael Iskedjian, John Walker, Colin Vicente, et al.
ISRN Ophthalmology|February 22, 2014
Patient race, reported problems in using glaucoma medications, and adherenceBetsy Sleath, Susan J Blalock, David Covert, et al.
Current Medical Research and Opinion|May 19, 2005
Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysisJohn H Walker, Yvonne Buys, Graham Trope, et al.
Advances in Therapy|June 14, 2017
Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort AnalysisAnanth Viswanathan, Claudio Spera, Anmol Mullins, et al.
Indian Journal of Ophthalmology|December 17, 2008
Patient-reported barriers to glaucoma medication access, use, and adherence in southern IndiaBetsy L Sleath, R Krishnadas, Minhee Cho, et al.
Pageof 3